Neuroblastoma trials in China

In China 26 Also abroad 128

26 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Not yet taking people in China
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Where
Shenzhen
Age
1 year to 65 years
People
100
Run by
Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04637503
Phase 2Taking people
Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
Where
Tianjin
Age
0 years to 18 years
People
27
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07318831
Phase 1/2Taking people
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
Where
Guangzhou, Tianjin, Wuhan
Age
5 years and over
People
100
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT05701306
Early phase 1Taking people
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
Where
Chengdu
Age
1 year to 100 years
People
10
Run by
Sichuan University
See details and how to joinNCT07767630
Phase 1Taking people
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Where
Guangzhou
Age
2 years to 18 years
People
51
Run by
Sun Yat-sen University
See details and how to joinNCT07584499
No phaseTaking people
Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma
Where
Guangzhou
People
200
Run by
Sun Yat-sen University
See details and how to joinNCT07516678
Phase 1/2Taking people
Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Where
Shenzhen
Age
12 months to 21 years
People
36
Run by
Beijing Biotech
See details and how to joinNCT07502287
No phaseTaking people
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
Where
Beijing
Age
Up to 18 years
People
30
Run by
Beijing Children's Hospital
See details and how to joinNCT06818916
No phaseTaking people
Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
Where
Nanjing
Age
6 months and over
People
30
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07195500
No phaseTaking people
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
Where
Hangzhou
Age
Up to 18 years
People
200
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06852807
Early phase 1Taking people
Safety & Efficacy of IR-101 in Relapsed/Refractory Neuroblastoma
Where
Chengdu
Age
12 months and over
People
10
Run by
Sichuan University
See details and how to joinNCT07067346
Early phase 1Not yet taking people in China
GSL Synthetase Inhibitor Plus GM-CSF and/ or Immune Checkpoint Inhibitor in Previously Treated High-Risk Neuroblastoma.
Where
Beijing
Age
6 years to 12 years
People
10
Run by
Chinese PLA General Hospital
See details and how to joinNCT07090538
No phaseTaking people
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Where
Nanjing
Age
Up to 18 years
People
150
Run by
Nanjing First Hospital, Nanjing Medical University
See details and how to joinNCT07064746
Phase 2Taking people
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Where
Guangzhou
Age
12 months and over
People
120
Run by
Sun Yat-Sen University Cancer Center
See details and how to joinNCT06013618
No phaseEnrolling by invitation
Risk Model for Metastasis Detection of Neuroblastoma
Where
Hangzhou, Shanghai, Shenzhen
People
500
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06703944
Phase 2Taking people
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
Where
Guangzhou
Age
18 months to 18 years
People
92
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06933394
No phaseNot yet taking people in China
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Where
Guiyang
Age
5 years to 16 years
People
360
Run by
RenJi Hospital
See details and how to joinNCT06873672
Phase 1/2Taking people
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
Where
Dongguan, Guangzhou, Shanghai
Age
1 year to 50 years
People
10
Run by
Sun Yat-Sen University Cancer Center
See details and how to joinNCT06836505
Phase 1Taking people
Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
Where
Guangzhou
Age
1 day to 18 years
People
30
Run by
Sun Yat-sen University
See details and how to joinNCT06631391
Phase 1Taking people
Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
Where
Nanjing
Age
1 year to 12 years
People
12
Run by
Nanjing Children's Hospital
See details and how to joinNCT06751134
Early phase 1Taking people
A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
Where
Chengdu
Age
1 year to 18 years
People
30
Run by
The General Hospital of Western Theater Command
See details and how to joinNCT06684639
No phaseTaking people
Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
Where
Guanzhou
Age
1 year to 21 years
People
64
Run by
Guangzhou Women and Children's Medical Center
See details and how to joinNCT06574698
Early phase 1Taking people
18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Where
Beijing
Age
1 year to 80 years
People
150
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05069220
Phase 2Taking people
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Where
Shanghai
Age
18 years and over
People
25
Run by
Hongmeng Yu
See details and how to joinNCT06255210
Phase 1Taking people
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Where
Jinan, Tianjin
Age
1 year and over
People
24
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT05562024